Classification and management of necrotising vasculitides

Drugs

Volumn 53, Issue 5, 1997, Pages 805-816

  Guillevin, Loïc ^a   Lhote, François ^a  

^a UNIVERSITÉ PARIS 13   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTIVIRUS AGENT; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYTOTOXIC AGENT; IMMUNOMODULATING AGENT; NEUTROPHIL CYTOPLASMIC ANTIBODY;

CHURG STRAUSS SYNDROME; CRYOGLOBULINEMIA; DISEASE CLASSIFICATION; HEPATITIS B VIRUS; HEPATITIS C VIRUS; NECROTIZING ARTERITIS; PATHOGENESIS; PLASMAPHERESIS; POLYARTERITIS NODOSA; REVIEW; WEGENER GRANULOMATOSIS;

HEPATITIS B VIRUS; HEPATITIS C VIRUS;

EID: 0030933995     PISSN: 00126667     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003495-199753050-00006     Document Type: Review

References (43)

1. Lie J. Nomenclature and classification of vasculitis: plus ça change, plus c'est la même chose. Arthritis Rheum 1994; 37: 181-6
2. Jennette JC, Falk RJ, Andnissy K, et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994; 37: 187-92
3. Kallenberg CG, Mulder AH, Tervaert JW. Antineutrophil cytoplasmic antibodies: a still-growing class of autoantibodies in inflammatory disorders. Am J Med 1992; 93: 675-82
4. Guillevin L, Visser H, Noel LH, et al. Antineutrophil cytoplasm antibodies in systemic polyarteritis nodosa with and without hepatitis B virus infection and Churg-Strauss syndrome - 62 patients. J Rheumatol 1993; 20: 1345-9
5. Fauci A, Haynes B, Katz P. The spectrum of vasculitis: clinical, pathologic, immunologic and therapeutic considerations. Ann Intern Med 1978; 89: 660-76
6. Guillevin L, Fechner J, Godeau P, et al. Périartérite noueuse: étude clinique et thérapeutique de 126 patients suivis durant 23 ans. Ann Med Interne (Paris) 1985; 136: 6-12
7. Lightfoot RJ, Michel BA, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa. Arthritis Rheum 1990; 33: 1088-93
8. Guillevin L, Lê THD, Godeau P, et al. Clinical findings and prognosis of polyarteritis nodosa and Churg-Strauss angiitis: a study in 165 patients. Br J Rheumatol 1988; 27: 258-64
9. Lhote F, Guillevin L. Polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: clinical aspects and treatment. Rheum Dis Clin North Am 1995; 21: 911-47
10. Guillevin L, Ronco P, Verroust P. Circulating immune complexes in systemic necrotizing vasculitis of the polyarteritis nodosa group. Comparison of HBV-related polyarteritis nodosa and Churg-Strauss angiitis. J Autoimmun 1990; 3: 789-92
11. Davson J, Ball J, Platt R. The kidney in periarteritis nodosa. Q J Med 1948; 17: 175-202
12. Savage C, Winearls C, Evans D, et al. Microscopic polyarteritis: presentation, pathology and prognosis. Q J Med 1985; 56: 467-83
13. Guillevin L, Lhote F, Brauner M, et al. Antineutrophil cytoplasmic antibodies (ANCA) and abnormal angiograms in polyarteritis nodosa and Churg-Strauss syndrome: indications for the diagnosis of microscopic polyangiitis. Ann Med Interne (Paris) 1995; 146: 548-50
14. Churg J, Strauss L. Allergic granulomatosis, allergic angiitis and periarteritis nodosa. Am J Pathol 1951; 27: 277-94
15. Phanupak P, Kohler P. Onset of polyarteritis nodosa during allergic hyposensitization treatment. Am J Med 1980; 68: 479-85
16. Guillevin L, Guittard T, Blétry O, et al. Systemic necrotizing angiitis with asthma: Causes and precipitating factors in 43 cases. Lung 1987; 165: 165-72
17. Haas C, Geneau C, Odinot JM, et al. Angéïte allergique et granulomateuse de Churg et Strauss: une étude rétrospective de 16 cas. Ann Med Interne (Paris) 1991; 142: 335-42
18. Wegener F. Über generalisierte septische Gefässerkrankungen. Verh Dtsch Ges Pathol 1936; 29: 202-10
19. van der Woude F, Rasmussen N, Lobatto S, et al. Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet 1985; I: 425-9
20. Gross WL, Schmitt WH, Csernok E. Antineutrophil cytoplasmic autoantibody-associated diseases: a rheumatologist's perspective. Am J Kidney Dis 1991; 18: 175-9
21. Brouet J, Clauvel J, Danon F, et al. Biologic and clinical significance of cryoglobulins: a report of 86 cases. Am J Med 1974; 57: 775-88
22. Agnello V, Chung RT, Kaplan LM. A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 1992; 327: 1490-5
23. Ferri C, Greco F, Longombardo G, et al. Association between hepatitis C virus and mixed cryoglobulinemia. Clin Exp Rheumatol 1991; 9: 621-4
24. Misiani R, Bellavita P, Fenili D, et al. Hepatitis C virus infection in patients with essential mixed cryoglobulinemia. Ann Intern Med 1992; 117: 573-7
25. Guillevin L, Lhote F, Jarrousse B, et al. Treatment of polyarteritis nodosa and Churg-Strauss syndrome: a meta-analysis of 3 prospective controlled trials including 182 patients over 12 years. Ann Med Interne (Paris) 1992; 143: 405-16
26. Guillevin L, Jarrousse B, Lok C, et al. on behalf of the Cooperative Study Group for Polyarteritis Nodosa. Longterm follow-up after treatment of polyarteritis nodosa and Churg-Strauss angiitis with comparison of steroids, plasma exchange and cyclophosphamide to steroids and plasma exchange: a prospective randomized trial of 71 patients. J Rheumatol 1991; 18: 567-74
27. Hoffman GS, Kerr GS, Leavitt RY, et al. Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 1992; 116: 488-98
28. Jarrousse B, Guillevin L, Bindi P, et al. Increased risk of Pneumocystis carinii pneumonia in patients with Wegener's granulomatosis. Clin Exp Rheumatol 1993; 11: 615-21
29. Godeau B, Coutant PV, Le THD, et al. Pneumocystis carinii pneumonia in the course of connective tissue disease: report of 34 cases. J Rheumatol 1994; 21: 246-51
30. Guillevin L, Lhote F, Cohen P, et al. Corticosteroids plus pulse cyclophosphamide and plasma exchanges versus corticosteroids plus pulse cyclophosphamide alone in the treatment of polyarteritis nodosa and Churg-Strauss syndrome patients with factors predicting poor prognosis: a prospective, randomized trial in sixty-two patients. Arthritis Rheum 1995; 38: 1638-45
31. Guillevin L, Lhote F, Gayraud M, et al. Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome: a prospective study in 342 patients. Medicine (Baltimore) 1996; 75: 17-28
32. Lhote F, Guillevin L. Treatment of polyarteritis nodosa and microscopic polyangiitis. Ann Med Interne (Paris) 1994; 145: 550-65
33. Genereau T, Lortholary O, Leclerq P, et al. Treatment of systemic vasculitis with cyclophosphamide and steroids: daily oral low-dose cyclophosphamide administration after failure of a pulse intravenous high-dose regimen in four patients. Br J Rheumatol 1994; 33: 959-62
34. Guillevin L, Fain O, Lhote F, et al. Lack of superiority of steroids plus plasma exchange to steroids alone in the treatment of polyarteritis nodosa and Churg-Strauss syndrome: a prospective, randomized trial in 78 patients. Arthritis Rheum 1992; 35: 208-15
35. Cacoub P, Le TH, Guillevin L, et al. Causes de décès dans les vascularites systémiques du groupe de la périartérite noueuse: analyse d'une série de 165 patients. Ann Med Interne (Paris) 1988; 139: 381-90
36. Guillevin L, Lhote F, Cohen P, et al. Polyarteritis nodosa related to hepatitis B virus: a prospective study with long-term observation of 41 patients. Medicine (Baltimore) 1995; 74: 238-53
37. Gross WL. New developments in the treatment of systemic vasculitis. Curr Opin Rheumatol 1994; 6: 11-9
38. Stegeman C, Cohen-Tervaert J, de Jong P, et al. Trimethoprimsulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener's granulomatosis. N Engl J Med 1996; 335: 16-20
39. Ferri C, Marzo E, Longombardo G, et al. Interferon-alpha in mixed cryoglobulinemia patients: a randomized, crossover-controlled trial. Blood 1993; 81: 1132-6
40. Ferri C, Marzo E, Longombardo G, et al. Interferon alfa-2b in mixed cryoglobulinaemia: a controlled crossover trial. Gut 1993; 34 Suppl. 2: S144-5
41. Cohen P. Tri Nguyen Q, Ferrière F, et al. Treatment of mixed cryoglobulinemia with recombinant interferon alpha and adjuvant therapies. Ann Med Intern (Paris) 1996; 147: 81-6
42. Misiani R, Bellavita P. Fenili D, et al. Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus. N Engl J Med 1994; 330: 751-6
43. Guillevin L, Le Clerc P, Jarrousse B, et al. Treatment of severe Wegener's granulomatosis: a prospective trial in 58 patients comparing prednisone (CS) and pulse cyclophosphamide (CY) versus CS and oral CY [abstract]. Arthritis Rheum 1994; 37 Suppl. 9: S352